Beth Livengood, ND - Gastroparesis Case Study (2017 Conference) (LDN, low dose naltrexone)

A case of gastroparesis and how low dose naltrexone helped this patient. Causes, symptoms, diagnostic findings, similar pathologies, demographics, and treatments, including diet, low dose naltrexone, acupuncture, etc; and the mechanisms of action of these treatments.

 

Debbie Rice, ND - LDN: regulating immune and inflammatory response (2017 Conference) (LDN, low dose naltrexone)

Two cases of Hashimoto's case where the patients stabilized on LDN. A Crohn’s case that took 3 months for LDN to have full effect

 

Darin Ingels, ND - LDN and Children (2017 Conference) (LDN, low dose naltrexone)

Research on LDN in children shows it is safe with low side effects. Studies where LDN was used successfully in children: 2 with Crohn’s, 2 with autism, 1 with CRPS. His cases: autism; Hashimoto’s; IBS.

 

Paul Anderson, NMD - Crohn's Disease: Latest Integrative Immunologic Therapies (2017 Conference) (LDN, low dose naltrexone)

Immune dysregulation and Crohn’s Disease. Integrated medical approaches. Low dose naltrexone (LDN) dosing, management of side effects, caution on opiates and LDN. LDN works synergistically with therapies, allows reduction of other Crohn’s medications.

 

Cory Tichauer, ND - LDN and Lyme Disease II (2017 Conference) (LDN, low dose naltrexone)

 

Armin Schwarzbach, MD, PhD - Lyme Borreliosis (2017 Conference) (LDN, low dose naltrexone)

Lyme borreliosis symptoms and coinfections, modern lab tests, new therapy options in chronic Lyme disease

 

Tom O'Bryan, DC - Fire in the Hole: Intestinal Permeability (2017 Conference) (LDN, low dose naltrexone)

 

Paul Battle PA-C - A Novel Approach to Type 1 Diabetes Mellitus (2017 Conference) (LDN, low dose naltrexone)

 

Mark Cooper, PhD - LDN, Neuroinflammation, and Movement Disorders (2018 Conference) (LDN, low dose naltrexone)

 

John Bardsley - Using unlicensed medicines as a part of patient care (2018 Conference) (LDN, low dose naltrexone)

John Bardsley is a pharmacist who has spent 15 years in the supply chain managing small to medium sized businesses in terms of GMP manufacture and GDP distribution throughout the UK.